Effect of different buffers on the biocompatibility of CAPD solutions

Peritoneal Dialysis International

Volumn 16, Issue SUPPL. 1, 1996, Pages

  Schambye, Hans Thalsgård ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bicarbonate; Biocompatibility; Cytotoxicity; Intracellular acidification; Lactate; Pyruvate

Indexed keywords

BICARBONATE; BUFFER; CALCIUM CARBONATE; CARBON DIOXIDE; CYTOKINE; DIALYSIS FLUID; GLUCOSE; GLUTAMINE; HISTIDINE; LACTIC ACID; POTASSIUM; PYRUVIC ACID;

ACIDIFICATION; BACTERICIDAL ACTIVITY; BIOCOMPATIBILITY; CELL FUNCTION; CELL MEMBRANE; CELL METABOLISM; CELL PH; CELL VIABILITY; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CYTOTOXICITY; DIFFUSION; HYPEROSMOLALITY; METABOLITE; OXIDATION REDUCTION POTENTIAL; PERITONEAL CAVITY; PH; PHAGOCYTOSIS; PRIORITY JOURNAL; SEDIMENT; STORAGE;

EID: 0029953197     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089601601s24     Document Type: Conference Paper

References (48)

1. Hau T. Bacteria, toxins, and the peritoneum. World J Surg 1990; 14:167-75.
2. Dunn DL, Barke RA, Ewald DC, Simmons RL. Macrophages and translymphatic absorption represent the first line of host defense of the peritoneal cavity. Arch Surg 1987; 122:102-10.
3. Lewis SL, Holmes CJ. Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1991; 11:14-21.
4. Holmes CJ, Lewis SL. Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1991; 11:112-17.
5. Glancey GR, Cameron JS, Ogg CS. Peritoneal drainage: an important element in host defence against staphylococcal peritonitis in patients on CAPD. Nephrol Dial Transplant 1992; 7:627-31.
6. Veech RL. The toxic impact of parenteral solutions on the metabolism of cells: a hypothesis for physiological parenteral therapy. Am J Clin Nutr 1986; 44:519-50.
7. Kristensen SR, Pedersen FB. Cytotoxicity testing of two CAPD dialysis fluids in a model system of quiescent fibroblasts.Nephrol Dial Transplant 1993;8:163-7.
8. Henderson IS, Couper IA, Lumsden A. Potentially irritant glucose metabolites in unused CAPD fluid. In: Maher JF, Winchester JF, eds. New York: Field, Rich and Ass., 1986:261-4.
9. Wieslander AP, Nordin MK, Kjellstrand PTT, Boberg UC. Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int 1991; 40:77-9.
10. Nilsson-Thorell CB, Muscalu N, Andrén AHG, Kjellstrand PTT, Wieslander AP. Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes. Perit Dial Int 1993; 13:208-13.
11. Wieslander AP, Nordin MK, Martinson E, Kjellstrand PTT, Boberg UC. Heat sterilized PD-fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. Clin Nephrol 1993; 39:343-8.
12. Wieslander AP, Svenson E, Forsbäck G, Deppisch R.In vitro biocompatibility of a heat sterilized, low-toxic and less acidic fluid for peritoneal dialysis. Perit Dial Int 1995; 15:158-64.
13. Schambye HT, Pedersen FB, Wang P. Cytotoxicity of continuous ambulatory peritoneal dialysis (CAPD) solutions. A biocompatibility study applying human polymorphonuclear granulocytes rather than laboratory animals. ATLA 1992; 20:275-9.
14. Alobaidi HM, Coles GA, Davies M, Lloyd D. Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function. Nephrol Dial Transplant 1986; 1:16-21.
15. Harvey DM, Sheppard KJ, Morgan AG, Fletcher J. Effect of dialysate fluids on phagocytosis and killing by normal neutrophils. J Clin Microbiol 1987; 8:1424-7.
16. Bronswijk Gv, Verbrugh HA, Heezius HC, Meulen Jvd, Oe LP, Verhoef J. Dialysis fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis.Eur J Clinc Microbiol Infect Dis 1988;3:368-73.
17. Steinhauer HB, Brugger U, Atmanspacher R, Lubrich-Birkner I, Schollmeyer P. Effect of CAPD dialysate on the release of eicosanoids and cytokines from human peritoneal macrophages. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1992; 8:47-52.
18. Bronswijk Gv, Verbrugh HA, Bos HJ, et al. Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. Perit Dial Int 1989; 9:197-202.
19. Di Paolo ND, Garosi G, Traversari L, Paolo MD. Mesothelial biocompatibility of peritoneal dialysis solutions. Perit Dial Int 1993; 13:109-12.
20. Topley N, Alobaidi HM, Davies M, Coles GA, Williams JD, Lloyd D. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 1988; 34:404-11.
21. Schambye HT, Pedersen FB, Wang P. Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin Inc., 1992; 8:42-6.
22. Peterson PK, Lee D, Suh HJ, Devalon M, Nelson RD, Keane WF. Intracellular survival of Candida albicans in peritoneal macrophages from chronic peritoneal dialysis patients. Am J Kidney Dis 1986; 2:146-52.
23. McGregor SJ, Brock JH, Briggs JD, Junor BJ. Bactericidal activity of peritoneal macrophages from continuous ambulatory dialysis patients. Nephrol Dial Transplant 1987; 2:104-8.
24. Beelen RHJ, Meulen Jvd, Verbrugh HA, Hoefsmit EC, Oe LP, Verhoef J. CAPD, a permanent state of peritonitis: a study on peroxidase activity. In: Maher JF, Winchester JF, eds. Frontiers in peritoneal dialysis. New York: Field, Rich and Ass., 1986:524-30.
25. Bos HJ, Meyer F, de Veld JC, Beelen RHJ. Peritoneal dialysis fluid induces change of mononuclear phagocyte proportions. Kidney Int 1989; 36:20-6.
26. DeFijter CWH, Verbrugh HA, Peters EDJ, et al. In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of the peritoneal macrophages in CAPD. Clin Nephrol 1993; 39:75-80.
27. McGregor SJ, Brock JH, Briggs JD, Junor BJ. Longitudinal study of peritoneal defense mechanisms in patients on continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1989; 9:115-19.
28. Lin CY, Ku WL, Huang TP. Serial peritoneal macrophage function studies in new and established continuous ambulatory peritoneal dialysis patients.Am. J Nephrol 1990; 10:368-73.
29. Liberek T, Topley N, Jörres A, et al. Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron 1993; 65:260-5.
30. Hemptinne A, Marrannes R, Vanheel B. Influence of organic acids on intracellular pH. Am J Physiol 1983; 245:178-83.
31. Simchowitz L, Textor JA. Lactic acid secretion by human neutrophils. J Gen Physiol 1992; 100:341-67.
32. Yu AW, Zhou XJ, Zhou FQ, et al. Neutrophilic intracellular acidosis induced by conventional, lactate-containing peritoneal dialysis solutions. Int J Artif Organs 1992; 15:6615.
33. Ing TS, Zhou XJ, YuAW, Zhou FQ, Vaziri ND. Lactate-containing peritoneal dialysis solutions. Int J Artif Organs 1993; 16:688-93.
34. Simchowitz L. Intracellular pH modulates the generation of Superoxide radicals by human neutrophils. J Clin Invest 1985; 76:1079-89.
35. Borregaard N, Herlin T. Energy metabolism of human neutrophils during phagocytosis. J Clin Invest 1982; 70:550-7.
36. Ing TS, Daugirdas JT, Gandhi VC, Popli S. Bicarbonate-buffered peritoneal dialysis (Editorial).Int J Artif Organs 1985; 8:121-4.
37. Bunchman TE, Ballal SH. Treatment of inflow pain by pH adjustment of dialysate in peritoneal dialysis.Perit Dial Int 1991; 11:179-80.
38. Feriani M, Dissegna D, La Greca G, Passlick-Deetjen J. Continuous ambulatory peritoneal dialysis with bicarbonate buffer - a pilot study.Perit Dial Int 1993; 13:88-91.
39. Jörres A, Gahl GM, Topley N, et al. In vitro biocompatibility of alternative CAPD fluids; comparison of bicarbonate-buffered and glucose-polymer-based solutions. Nephrol Dial Transplant 1994; 9:785-90.
40. Manahan FJ, Ing BL, Chan JC, et al. Effects of bicarbonate-containing versus lactate-containing peritoneal dialysis solutions on Superoxide production by human neutrophils. Artif Organs 1989; 13:495-7.
41. Dobos GJ, Bühler J, Sach M, et al. Bicarbonate-based dialysis solution improves calcium mobilization in fMLP-stimulated neutrophils. (Abstract) J Am Soc Nephrol 1994; 5:413.
42. Schambye HT, Flesner P, Pedersen RB, et al. Bicarbonate versus lactate based CAPD fluids. A biocompatibility study in rabbits. Perit Dial Int 1992; 12:281-6.
43. Schambye HT, Pedersen FB, Christensen HK, Berthelsen H, Wang P. The cytotoxicity of continuous ambulatory peritoneal dialysis solutions with different bicarbonate/lactate ratios. Perit Dial Int 1993; 13:116-18.
44. Ritter JM, Doktor HS, Benjamin N. Paradoxical effect of bicarbonate on cytoplasmic pH. Lancet 1990; 335:1243-6.
45. Zhou XJ, Yu AW, Zhou FQ, Ing TS, Vaziri ND. Effects of an acidic, lactate-based peritoneal dialysis solution and its euhydric, bicarbonate-based counterpart on neutrophilic intracellular pH.Int J Artif Organs 1993; 16:816-19.
46. Topley N, Mackenzie R, Petersen MM, et al. In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid.Nephrol Dial Transplant 1991; 6:574-81.
47. Mahiout A, Brunkhorst R. Pyruvate anions neutralize peritoneal dialysate cytotoxicity. Nephrol Dial Transplant 1995; 10:391-4.
48. Simchowitz L, Vogt SK. Substrate and inhibitor specificity of the lactate carrier of human neutrophils. J Membr Biol 1993; 131:23-34.